Analyst firms · Raymond James · NKTX
Raymond James NKTX price target and rating history
Nkarta Inc. (NKTX) · Health Care
Raymond James rates Nkarta Inc. (NKTX) Strong Buy with a $16 price target, as of its latest action on Aug 14, 2024. It has published 3 rating actions on NKTX since March 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Strong Buy
- Price target
- $16
- Median target, all firms
- Too few
- Actions on NKTX
- 3
Raymond James price target on NKTX
Every Raymond James rating on NKTX
- Aug 14, 2024
- Mar 22, 2024
- Mar 11, 2022
How other firms rate NKTX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Buy | $12 | Nov 2, 2026 |
| TD Cowen | Buy | Jun 23, 2026 |
Questions about Raymond James and NKTX
- What is Raymond James's price target for NKTX?
- Raymond James's latest stated price target for Nkarta Inc. (NKTX) is $16, from its action on Aug 14, 2024.
- What is Raymond James's rating on NKTX?
- Raymond James rates NKTX Strong Buy, a bullish rating, as of Aug 14, 2024.
- When did Raymond James last change its view on NKTX?
- On Aug 14, 2024, Raymond James upgrades to Strong Buy from Outperform, price target $16.
All Raymond James ratingsNKTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.